Status:
COMPLETED
Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Autism Spectrum Disorder
Developmental Delay
Eligibility:
All Genders
15-3 years
Phase:
NA
Brief Summary
In this study, the investigators are trying to find new ways to screen for autism spectrum disorder (ASD) in young children. The investigators want to see if people like pediatricians can screen child...
Detailed Description
The investigators will evaluate and compare two telemedicine assessment tools (TELE-STAT and TELE-ASD-PEDS) that could allow parents or naive providers in remote locations to complete an Autism Spectr...
Eligibility Criteria
Inclusion
- Children who have been diagnosed with autism or developmental delay
Exclusion
- Children with genetic disorders
- Children with medical complexities, such as blindness or deafness
- Children whose families do not speak English
Key Trial Info
Start Date :
March 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT03847337
Start Date
March 4 2019
End Date
September 30 2021
Last Update
November 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212